{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:54:58Z","timestamp":1753890898205,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Congenital erythropoietic porphyria (CEP, OMIM #263700) is a rare autosomal recessive disease characterized by skin photosensitivity, hypertrichosis, scarring in light-exposed areas, erythrodontia, and dark-reddish urine. The severity of the clinical phenotype is directly associated with the complete loss of enzymatic activity resulting from UROS mutations.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To understand the genetic etiology of CEP in a 9-year-old female proband, we checked clinical data and collected peripheral blood samples from her and her parents. Genomic DNA was isolated and subjected to polymerase chain reaction (PCR) amplification. Sanger sequencing was performed to detect potential mutations. Bioinformatics analysis was performed to assess the pathogenicity of the identified variant, and 3D protein modeling was conducted to predict its impact on protein structure.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The proband presents with red wine-colored urine in early infancy, reddish-brown, notched incisors, and vellus hair on the forehead and trunk. Blisters develop on sun-exposed areas, leaving hyperpigmented macules after rupture. Sanger sequencing identified a previously reported missense mutation (c 0.425C &amp;gt; T: p.P142L) and a novel nonsense mutation in the UROS gene (c 0.325A &amp;gt; T: p.K109*). Bioinformatic analysis indicated that the c 0.325A &amp;gt; T: p.K109* variant is pathogenic. Structural modeling demonstrated that the heterozygous c.325A &amp;gt; T transversion in exon 6 of UROS caused a K109 termination at the protein\u2019s \u03b16 helix chain.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our findings underscored the critical role of Sanger sequencing in the accurate diagnosis of atypical CEP cases and in facilitating informed genetic counseling. The identification of a UROS gene novel mutation in this case indicates a mild phenotype, further expanding the spectrum of disorders associated with UROS variants.<\/jats:p>","DOI":"10.3389\/fgene.2025.1486595","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T09:12:50Z","timestamp":1743412370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a novel nonsense mutation and a recurrent missense mutation in UROS gene in a patient with congenital erythropoietic porphyria"],"prefix":"10.3389","volume":"16","author":[{"given":"Ning","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusupu","family":"Yimin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/bjd.14675","article-title":"Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation","volume":"175","author":"Aguilera","year":"2016","journal-title":"Br. J. Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.2000.6373","article-title":"Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression","volume":"70","author":"Aizencang","year":"2000","journal-title":"Genomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani","year":"2012","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2119\/molmed.2012.00340","article-title":"Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2119\/molmed.2013.00003","article-title":"Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria","volume":"19","author":"Bishop","year":"2013","journal-title":"Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/hmg\/ddx067","article-title":"Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition","volume":"26","author":"Blouin","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2141.2002.03557.x","article-title":"Congenital erythropoietic porphyria: advances in pathogenesis and treatment","volume":"117","author":"Desnick","year":"2002","journal-title":"Br. J. Haematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ymgme.2018.12.008","article-title":"Congenital erythropoietic porphyria: recent advances","volume":"128","author":"Erwin","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1432-1327.1998.2570149.x","article-title":"Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria congenital erythropoietic porphyria","volume":"257","author":"Freesemann","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2133.2012.11160.x","article-title":"Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases porphyria: a single-observer clinical study of 29 cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br. J. Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1093\/emboj\/20.21.5832","article-title":"Crystal structure of human uroporphyrinogen III synthase","volume":"20","author":"Mathews","year":"2001","journal-title":"EMBO J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3324\/haematol.2019.228270","article-title":"Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria","volume":"106","author":"Mirmiran","year":"2021","journal-title":"Haematologica"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1007\/s11033-012-1497-z","article-title":"Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria","volume":"39","author":"Moghbeli","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1046\/j.1365-2141.2002.03558.x","article-title":"Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene","volume":"117","author":"Shady","year":"2002","journal-title":"Br. J. Haematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.6026\/97320630081265","article-title":"Phylogenetic analysis of uroporphyrinogen III synthase (UROS) gene","volume":"8","author":"Shaik","year":"2012","journal-title":"Bioinformation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1172\/JCI10642","article-title":"Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria","volume":"107","author":"Solis","year":"2001","journal-title":"J. Clin. Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.gastro.2019.04.050","article-title":"Clinical guide and update on porphyrias","volume":"157","author":"St\u00f6lzel","year":"2019","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF02281859","article-title":"A novel point mutation in congenital erythropoietic porphyria in two members of Japanese family","volume":"97","author":"Tanigawa","year":"1996","journal-title":"Hum. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ymgme.2018.08.015","article-title":"Congenital erythropoietic porphyria and erythropoietic protoporphyria: identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations","volume":"128","author":"Weiss","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI117742","article-title":"Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene","volume":"95","author":"Xu","year":"1995","journal-title":"J. Clin. Invest"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1486595\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T09:12:51Z","timestamp":1743412371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1486595\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":22,"alternative-id":["10.3389\/fgene.2025.1486595"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1486595","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"1486595"}}